MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1969.29%
Quick Ratio
1969.29%
Cash Ratio
280.82%
Debt to Asset Ratio
5.06%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Series b redeemable convertible ...
    • Others

Balance Sheets
2026-06-30
Cash and cash equivalents
26,903
Marketable securities
159,538
Prepaid expenses
1,359
Other current assets
858
Total current assets
188,658
Right of use assets - operating leases, net
524
Right of use assets - financing leases, net
0
Total property and equipment
650
Less accumulated depreciation and amortization
606
Property and equipment, net
44
Other non-current assets
80
Total assets
189,306
Accounts payable and accrued expenses
7,573
Compensation and employee benefits liabilities
1,415
Operating lease liabilities, current
592
Financing lease liabilities, current
0
Total current liabilities
9,580
Operating lease liabilities, non-current
0
Other non-current liabilities
1
Total liabilities
9,581
Series b redeemable convertible preferred stock, 0.0001 par value 502 and zero shares authorized as of june 30, 2026 and december 31, 2025, respectively 502 and zero shares issued and outstanding as of june 30, 2026, and december 31, 2025, respectively liquidation value of 0 as of june 30, 2026
6,767
Common stock, 0.0001 par value 300,000,000 shares authorized as of june 30, 2026 and 12,500,000 shares authorized as of december 31, 2025 25,832,969 and 1,261,685 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
2
Additional paid-in capital
642,399
Accumulated deficit
-469,380
Accumulated other comprehensive (loss) income
-63
Total stockholders' equity
172,958
Total liabilities, redeemable convertible preferred stock, and stockholders' equity
189,306
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$159,538K Cash and cashequivalents$26,903K Prepaid expenses$1,359K Other current assets$858K Total property andequipment$650K Total current assets$188,658K Right of use assets -operating leases, net$524K Other non-currentassets$80K Property and equipment,net$44K Less accumulateddepreciation and...$606K Total assets$189,306K Total liabilities,redeemable convertible...$189,306K Total stockholders'equity$172,958K Total liabilities$9,581K Series b redeemableconvertible preferred...$6,767K Accumulated deficit-$469,380K Accumulated othercomprehensive (loss) income-$63K Additional paid-in capital$642,399K Total currentliabilities$9,580K Other non-currentliabilities$1K Common stock, 0.0001par value...$2K Accounts payable andaccrued expenses$7,573K Compensation and employeebenefits liabilities$1,415K Operating leaseliabilities, current$592K

Faeth Therapeutics, Inc. (FTH)

Faeth Therapeutics, Inc. (FTH)